We wrote in early 2024 that orthopedic funding announcements had slowed in recent years. Lingering market disruption and changing investor attitudes drove 2023 funding activity to its lowest level in nearly a decade.
However, orthopedic investments through the first half of 2024 have the industry on pace for a big leap.
We tracked 21 funding announcements during the first half of the year. Since 2020, approximately 48% of funding has come in the first half of the year. So, the industry is on pace for 43 investments in 2024. In orthopedics’ recent history, only the unprecedented market conditions of 2021 drove more activity.
Of course, things could change at any time. But why might orthopedic investment activity bounce back in 2024?
First, investors have adapted to the new realities of the global markets over the past four years. Second, orthopedic investors required clear proof of improving market conditions. They got that and more with orthopedic’s buoyant growth rate in 2023 and early 2024. Finally, the industry is underpenetrated with technology, creating lucrative opportunities for innovation.
A fresh surge of innovation in orthopedics could be an important balancing agent as consolidation changes the competitive landscape across all of healthcare.
We wrote in early 2024 that orthopedic funding announcements had slowed in recent years. Lingering market disruption and changing investor attitudes drove 2023 funding activity to its lowest level in nearly a decade.
However, orthopedic investments through the first half of 2024 have the industry on pace for a big leap.
We tracked 21...
We wrote in early 2024 that orthopedic funding announcements had slowed in recent years. Lingering market disruption and changing investor attitudes drove 2023 funding activity to its lowest level in nearly a decade.
However, orthopedic investments through the first half of 2024 have the industry on pace for a big leap.
We tracked 21 funding announcements during the first half of the year. Since 2020, approximately 48% of funding has come in the first half of the year. So, the industry is on pace for 43 investments in 2024. In orthopedics’ recent history, only the unprecedented market conditions of 2021 drove more activity.
Of course, things could change at any time. But why might orthopedic investment activity bounce back in 2024?
First, investors have adapted to the new realities of the global markets over the past four years. Second, orthopedic investors required clear proof of improving market conditions. They got that and more with orthopedic’s buoyant growth rate in 2023 and early 2024. Finally, the industry is underpenetrated with technology, creating lucrative opportunities for innovation.
A fresh surge of innovation in orthopedics could be an important balancing agent as consolidation changes the competitive landscape across all of healthcare.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
